月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
由Adis International Limited（现为Wolters Kluwer Health的一部分）出版。国际标准书号：1177-1062。结合分子诊断的前沿内容和美国药物基因组学杂志，分子诊断和治疗为您带来了独立和权威的见解，最新的分子诊断和药物基因组技术，以提高患者的疾病诊断和治疗的个性化方式。联合期刊提供了更全面的见解：使用生物标志物指导药物开发，作为诊断手段，并针对特定人群定位药物；检测、监测和治疗疾病的分子原因；影响药物反应、药物代谢、不良反应的分子标志物和遗传变异。和/或疾病进展；分子疾病分类；药物/诊断组合（治疗学）；新兴的分子诊断工具和技术；病原体检测和耐药性分析；与个性化医学有关的伦理和监管问题。
https://www.editorialmanager.com/mdta/
Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1177-1062.Combining the cutting-edge content of Molecular Diagnosis and the American Journal of Pharmacogenomics, Molecular Diagnosis & Therapy brings you independent and authoritative insights into the latest molecular diagnostic and pharmacogenomic techniques to improve the diagnosis and treatment of disease in patients in an individualized manner. The combined journal provides more comprehensive insight into: Using biomarkers to guide drug development, serve as diagnostics, and target medicines toward specific populations; Detection, monitoring and treatment of the molecular causes of disease; Molecular markers and genetic variation affecting drug response, drug metabolism, adverse effects and/or disease progression; Molecular disease classification; Drug/diagnostic combinations (theranostics); Emerging molecular diagnostic tools and technologies; Pathogen detection and drug resistance analysis; Ethical and regulatory issues relating to personalized medicine.
